I-Mab Rebrands as NovaBridge Biosciences

Written by Emily J. Thompson, Senior Investment Analyst

Updated: Oct 29 2025

0mins

Corporate Name Change: I-Mab has officially changed its name to NovaBridge Biosciences, a decision approved by shareholders and the Board of Directors during an Extraordinary General Meeting on October 24, 2025.
New Trading Symbol: The company's American Depositary Shares will begin trading under the new ticker symbol "NBP" on Nasdaq starting October 30, 2025, replacing the previous symbol "IMAB".
Strategic Transformation: The rebranding is part of NovaBridge's strategic transformation into a global biotechnology platform focused on accelerating access to innovative medicines for patients worldwide.
Operational Model: The company plans to implement a "hub-and-spoke" model to create specialized subsidiary companies, allowing for focused management of specific assets and therapeutic areas to optimize risk and value creation.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.